FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Masimo RD SET for Pulse Oximetry Cleared

FDA clears a Masimo 510(k) for the RD SET sensors with Masimo Measure-through Motion and Low Perfusion SET pulse oximetry that is intended to provide ...

Federal Register

Priority Voucher Awarded to Leadiant Bioscience

Federal Register notice: FDA awards a priority review voucher to Leadiant Bioscience after determining that rare disease drug Revcovi (elapegademase-l...

Human Drugs

Economic Advisors Praise FDA on Drug Costs

The Council on Economic Advisors says FDA efforts to control drug prices are providing savings to consumers.

Human Drugs

Drug Supply Chain Verification System Guidance

FDA publishes a draft guidance on legal requirements for drug supply chain verification systems.

Human Drugs

FDA Approves Saxenda Label Update on CV Risk

FDA approves an updated label for Novo Nordisks Saxenda to add cardiovascular risk data for the drugs active ingredient from the LEADER trial of a dif...

Medical Devices

Servicing/Remanufacturing White Paper, Workshop

FDA issues a white paper outlining issues to be discussed at a December workshop on the distinctions between medical device servicing and remanufactur...

Medical Devices

Rocky Mountain Orthodontics Gains Orthocaps Clearance

FDA clears a Rocky Mountain Orthodontics 510(k) for Orthocaps, a transparent and removable appliance for correcting tooth malpositions.

Human Drugs

Tanezumab Study Meets Efficacy Endpoints

Pfizer and Lilly say a Phase 3 trial of their novel osteoarthritis monoclonal antibody met all three co-primary efficacy endpoints.

Human Drugs

Genentech Flu Drug Approved by FDA

FDA approves Genentechs Xofluza (baloxavir marboxil) for treating acute, uncomplicated influenza in people 12 years of age and older.

Federal Register

Joint Panel to Mull Increasing Naloxone in Communities

Federal Register notice: FDA announces a 12/17 joint advisory committee meeting to discuss strategies to increase the availability of naloxone product...